Aberrant activation of the PI3K/Akt/mTOR signalling pathway leads to an increase in chemokine (C-X-C motif) receptor 4 (CXCR4), which corresponds to maintenance of stemness in NSCLC cells [55]. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.